A detailed history of First Horizon Advisors, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 183,186 shares of MRK stock, worth $18.5 Million. This represents 0.69% of its overall portfolio holdings.

Number of Shares
183,186
Previous 187,825 2.47%
Holding current value
$18.5 Million
Previous $24.8 Million 8.49%
% of portfolio
0.69%
Previous 0.77%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$123.8 - $132.96 $574,308 - $616,801
-4,639 Reduced 2.47%
183,186 $22.7 Million
Q1 2024

Apr 26, 2024

SELL
$113.24 - $131.95 $461,453 - $537,696
-4,075 Reduced 2.12%
187,825 $24.8 Million
Q4 2023

Feb 06, 2024

SELL
$100.18 - $109.02 $79,643 - $86,670
-795 Reduced 0.41%
191,900 $20.9 Million
Q3 2023

Oct 27, 2023

SELL
$102.95 - $114.33 $353,118 - $392,151
-3,430 Reduced 1.75%
192,695 $19.8 Million
Q2 2023

Aug 03, 2023

SELL
$108.61 - $118.38 $798,500 - $870,329
-7,352 Reduced 3.61%
196,125 $22.6 Million
Q1 2023

May 15, 2023

SELL
$102.94 - $114.86 $549,699 - $613,352
-5,340 Reduced 2.56%
203,477 $21.6 Million
Q4 2022

Feb 10, 2023

SELL
$87.44 - $112.11 $907,714 - $1.16 Million
-10,381 Reduced 4.74%
208,817 $23.2 Million
Q3 2022

Nov 09, 2022

SELL
$84.53 - $94.96 $672,774 - $755,786
-7,959 Reduced 3.5%
219,198 $18.9 Million
Q2 2022

Aug 02, 2022

BUY
$83.49 - $94.64 $3.55 Million - $4.03 Million
42,569 Added 23.06%
227,157 $20.7 Million
Q1 2022

May 10, 2022

SELL
$73.51 - $82.4 $2.77 Million - $3.1 Million
-37,676 Reduced 16.95%
184,588 $15.1 Million
Q4 2021

Feb 09, 2022

BUY
$72.28 - $90.54 $3.06 Million - $3.83 Million
42,312 Added 23.51%
222,264 $17 Million
Q3 2021

Nov 15, 2021

BUY
$71.68 - $78.83 $7,454 - $8,198
104 Added 0.06%
179,952 $13.5 Million
Q3 2021

Nov 09, 2021

BUY
$71.68 - $78.83 $9.78 Million - $10.8 Million
136,480 Added 314.7%
179,848 $13.5 Million
Q2 2021

Aug 09, 2021

BUY
$70.31 - $77.77 $56,107 - $62,060
798 Added 1.87%
43,368 $3.37 Million
Q1 2021

May 11, 2021

BUY
$68.86 - $81.11 $93,718 - $110,390
1,361 Added 3.3%
42,570 $3.13 Million
Q4 2020

Feb 11, 2021

SELL
$71.77 - $79.65 $129,257 - $143,449
-1,801 Reduced 4.19%
41,209 $3.22 Million
Q3 2020

Nov 12, 2020

SELL
$73.18 - $82.95 $233,590 - $264,776
-3,192 Reduced 6.91%
43,010 $3.4 Million
Q2 2020

Jul 31, 2020

SELL
$70.42 - $80.13 $17,675 - $20,112
-251 Reduced 0.54%
46,202 $3.41 Million
Q1 2020

May 05, 2020

SELL
$63.36 - $87.82 $381,807 - $529,203
-6,026 Reduced 11.48%
46,453 $3.41 Million
Q4 2019

Jan 07, 2020

BUY
$77.58 - $87.54 $153,375 - $173,066
1,977 Added 3.91%
52,479 $4.55 Million
Q3 2019

Oct 23, 2019

SELL
$76.08 - $82.93 $432,666 - $471,622
-5,687 Reduced 10.12%
50,502 $4.06 Million
Q2 2019

Aug 05, 2019

SELL
$69.84 - $81.59 $194,993 - $227,799
-2,792 Reduced 4.73%
56,189 $0
Q1 2019

Apr 26, 2019

SELL
$69.58 - $79.36 $3.41 Million - $3.89 Million
-49,051 Reduced 45.4%
58,981 $0
Q4 2018

Feb 11, 2019

BUY
$65.24 - $75.71 $167,014 - $193,817
2,560 Added 2.43%
108,032 $7.88 Million
Q3 2018

Nov 05, 2018

BUY
$57.69 - $67.84 $4.25 Million - $4.99 Million
73,620 Added 231.13%
105,472 $0
Q3 2018

Nov 05, 2018

SELL
$57.69 - $67.84 $4.27 Million - $5.02 Million
-73,974 Reduced 69.9%
31,852 $0
Q2 2018

Aug 07, 2018

BUY
$50.83 - $59.72 $1.98 Million - $2.33 Million
39,021 Added 58.41%
105,826 $0
Q1 2018

May 02, 2018

BUY
$50.96 - $59.23 $15,338 - $17,828
301 Added 0.45%
66,805 $0
Q4 2017

Jan 25, 2018

BUY
$51.62 - $61.64 $205,137 - $244,957
3,974 Added 6.36%
66,504 $0
Q3 2017

Nov 09, 2017

BUY
$58.67 - $63.13 $222,124 - $239,010
3,786 Added 6.44%
62,530 $0
Q2 2017

Aug 14, 2017

BUY
N/A
58,744
58,744 $0

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $256B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track First Horizon Advisors, Inc. Portfolio

Follow First Horizon Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Horizon Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Horizon Advisors, Inc. with notifications on news.